Intention notice: reagents to qCPR CALR for Helse Bergen HF

Justification for direct procurement: The laboratory would like to change the analysis method to a more efficient and sensitive qPCR based method. The transition to qPCR significantly alters the test flow in the laboratory and increases patient safety by transferring sample numbers and analysis results directly from the instrument to …

CPV: 38000000 Лабораторно, оптично и прецизно оборудване (без стъклени изделия)
Място на изпълнение:
Intention notice: reagents to qCPR CALR for Helse Bergen HF
Издаващ орган:
SYKEHUSINNKJØP HF
Номер на наградата:
2025/44903

1. Buyer

1.1 Buyer

Official name : SYKEHUSINNKJØP HF

2. Procedure

2.1 Procedure

Title : Intention notice: reagents to qCPR CALR for Helse Bergen HF
Description : Justification for direct procurement: The laboratory would like to change the analysis method to a more efficient and sensitive qPCR based method. The transition to qPCR significantly alters the test flow in the laboratory and increases patient safety by transferring sample numbers and analysis results directly from the instrument to LIMS. Searches have been carried out in the market, but we have not found other suppliers who offer ready kits that are both compatible with our instrument and the CE-IVD brand. Reagents to CALR qPCR from TRUPCR have already been tested and validated in the laboratory. A change to another supplier will require new testing and validation, at the same time that the current method must be maintained during the transition period. This will be very resource demanding, both in the form of personnel resources and increased reagent costs, and it will not give any improvement in either sensitivity or specificity. Consequences of switching to another supplier: A change to another supplier will delay the start-up of the new method and thereby reduce patient safety. This can lead to an increased risk of downtime and reduced tenders, as the laboratory must then maintain two parallel analysis methods for a period of time. Conclusion: Direct procurement of TRUPCR reagents for qPCR CALR is considered necessary to ensure patient safety, continuity of laboratory operation and effective implementation of the new analysis method. The contracts will be signed without a prior tender notice, as according to what the contracting authority knows, there are no other suppliers who can fulfil the requirements in the market. Pursuant to procurements without a competition is the Public Procurement Regulations § 13-4 first section, letter b second point.  An intention notice is published in accordance with the provision in § 21-5. Any enquiries on the intention of signing the contract shall be directed to Mathias Høydal Nilsen by 15.09.2025.
Procedure identifier : 1af70f13-a424-4ea8-bf66-5ccb72b604fd
Internal identifier : 2025/44903
Type of procedure : Negotiated without prior call for competition

2.1.1 Purpose

Main nature of the contract : Supplies
Main classification ( cpv ): 38000000 Laboratory, optical and precision equipments (excl. glasses)

2.1.2 Place of performance

Country subdivision (NUTS) : Vestland ( NO0A2 )
Country : Norway

2.1.4 General information

Legal basis :
Directive 2014/24/EU
Anskaffelsesforskriften - a tender notice, as according to what the contracting authority knows, there are no other suppliers who can fulfil the requirements in the market. Pursuant to procurements without a competition is the Public Procurement Regulations § 13-4 first section, letter b second point. An intention notice is published in accordance with the provision in § 21-5.

5. Lot

5.1 Lot technical ID : LOT-0000

Title : Intention notice: reagents to qCPR CALR for Helse Bergen HF
Description : Justification for direct procurement: The laboratory would like to change the analysis method to a more efficient and sensitive qPCR based method. The transition to qPCR significantly alters the test flow in the laboratory and increases patient safety by transferring sample numbers and analysis results directly from the instrument to LIMS. Searches have been carried out in the market, but we have not found other suppliers who offer ready kits that are both compatible with our instrument and the CE-IVD brand. Reagents to CALR qPCR from TRUPCR have already been tested and validated in the laboratory. A change to another supplier will require new testing and validation, at the same time that the current method must be maintained during the transition period. This will be very resource demanding, both in the form of personnel resources and increased reagent costs, and it will not give any improvement in either sensitivity or specificity. Consequences of switching to another supplier: A change to another supplier will delay the start-up of the new method and thereby reduce patient safety. This can lead to an increased risk of downtime and reduced tenders, as the laboratory must then maintain two parallel analysis methods for a period of time. Conclusion: Direct procurement of TRUPCR reagents for qPCR CALR is considered necessary to ensure patient safety, continuity of laboratory operation and effective implementation of the new analysis method. The contracts will be signed without a prior tender notice, as according to what the contracting authority knows, there are no other suppliers who can fulfil the requirements in the market. Pursuant to procurements without a competition is the Public Procurement Regulations § 13-4 first section, letter b second point.  An intention notice is published in accordance with the provision in § 21-5. Any enquiries on the intention of signing the contract shall be directed to Mathias Høydal Nilsen by 15.09.2025.
Internal identifier : 2025/44903

5.1.1 Purpose

Main nature of the contract : Supplies
Main classification ( cpv ): 38000000 Laboratory, optical and precision equipments (excl. glasses)

5.1.2 Place of performance

Country subdivision (NUTS) : Vestland ( NO0A2 )
Country : Norway
Additional information :

5.1.6 General information

The procurement is covered by the Government Procurement Agreement (GPA) : yes

5.1.16 Further information, mediation and review

Review organisation : Indre og Østre Finnmark tingrett

6. Results

Direct award :
Justification for direct award : The contract can be provided only by a particular economic operator because of an absence of competition for technical reasons
Other justification : Justification for direct procurement: The laboratory would like to change the analysis method to a more efficient and sensitive qPCR based method. The transition to qPCR significantly alters the test flow in the laboratory and increases patient safety by transferring sample numbers and analysis results directly from the instrument to LIMS. Searches have been carried out in the market, but we have not found other suppliers who offer ready kits that are both compatible with our instrument and the CE-IVD brand. Reagents to CALR qPCR from TRUPCR have already been tested and validated in the laboratory. A change to another supplier will require new testing and validation, at the same time that the current method must be maintained during the transition period. This will be very resource demanding, both in the form of personnel resources and increased reagent costs, and it will not give any improvement in either sensitivity or specificity. Consequences of switching to another tenderer: A change to another supplier will delay the start of the new method and thereby reduce patient safety. This can lead to an increased risk of downtime and reduced tenders, as the laboratory must then maintain two parallel analysis methods for a period of time. Conclusion: The direct procurement of TRUPCR reagents for qPCR CALR is considered necessary to ensure patient safety, continuity of laboratory operation and effective implementation of the new analysis method. The contracts will be signed without a prior tender notice, as according to what the contracting authority knows, there are no other suppliers who can fulfil the requirements in the market. Pursuant to procurements without a competition is the Public Procurement Regulations § 13-4 first section, letter b second point. An intention notice is published in accordance with the provision in § 21-5. Any enquiries about the intention of signing the contract shall be directed to Mathias Høydal Nilsen by 15.09.2025.

6.1 Result lot ldentifier : LOT-0000

6.1.2 Information about winners

Winner :
Official name : TRUPCR Europe Limited
Tender :
Tender identifier : 403848
Identifier of lot or group of lots : LOT-0000
Contract information :
Identifier of the contract : 403848

8. Organisations

8.1 ORG-0001

Official name : SYKEHUSINNKJØP HF
Registration number : 916879067
Postal address : Postboks 40
Town : VADSØ
Postcode : 9811
Country subdivision (NUTS) : Finnmark/Finnmárku/Finmarkku ( NO073 )
Country : Norway
Contact point : Postmottak Sykehusinnkjøp
Telephone : +47 78950700
Roles of this organisation :
Buyer

8.1 ORG-0002

Official name : TRUPCR Europe Limited
Registration number : 12060630
Town : Manchester
Postcode : M15 6SE
Country : United Kingdom
Roles of this organisation :
Tenderer
Winner of these lots : LOT-0000

8.1 ORG-0003

Official name : Indre og Østre Finnmark tingrett
Registration number : 926722840
Town : Vadsø
Postcode : 9811
Country subdivision (NUTS) : Finnmark/Finnmárku/Finmarkku ( NO073 )
Country : Norway
Roles of this organisation :
Review organisation

Notice information

Notice identifier/version : 013c83d4-7426-47e5-858b-63fb6f77e674 - 01
Form type : Direct award preannouncement
Notice type : Voluntary ex-ante transparency notice
Notice dispatch date : 04/09/2025 08:43 +00:00
Notice dispatch date (eSender) : 04/09/2025 08:45 +00:00
Languages in which this notice is officially available : English
Notice publication number : 00579948-2025
OJ S issue number : 170/2025
Publication date : 05/09/2025